Cargando…

Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients

Background: Cirrhosis is a common chronic liver disease characterized by irreversible diffuse liver damage. Intestinal microbiome dysbiosis and metabolite dysfunction contribute to the development of cirrhosis. Lactitol (4-β-D-galactopyranosyl-D-glucitol) was previously reported to promote the growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Haifeng, Chen, Liang, Pan, Xiaxia, Yao, Yujun, Zhang, Hua, Zhu, Xiaofei, Lou, Xiaobin, Zhu, Chunxia, Wang, Jun, Li, Lanjuan, Wu, Zhongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551616/ https://www.ncbi.nlm.nih.gov/pubmed/34722597 http://dx.doi.org/10.3389/fmed.2021.762930

Ejemplares similares

Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial
por: Lu, Haifeng, et al.
Publicado: (2023)

Efficacy and tolerance of lactitol supplementation for adult constipation: a systematic review and meta-analysis
por: Miller, Larry E, et al.
Publicado: (2014)

Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae
por: Ramos-Ramos, Juan Carlos, et al.
Publicado: (2020)

Influence of Lactitol and Psyllium on Bowel Function in Constipated Indian Volunteers: A Randomized, Controlled Trial
por: Cheng, Jing, et al.
Publicado: (2019)

Mathematical modelling of mass transfer phenomena for sucrose and lactitol molecules during osmotic dehydration of cherries
por: Maldonado, Mariela, et al.
Publicado: (2022)

Crosstalk between liver macrophages and gut microbiota: An important component of inflammation-associated liver diseases
por: Zhou, Ziyuan, et al.
Publicado: (2022)

Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota
por: Collins, Stephanie L., et al.
Publicado: (2018)

The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study
por: Scarpellini, E., et al.
Publicado: (2022)

Microbiome–miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities
por: Lu, Haifeng, et al.
Publicado: (2021)

Independent and Combined Effects of Lactitol, Polydextrose, and Bacteroides thetaiotaomicron on Postprandial Metabolism and Body Weight in Rats Fed a High-Fat Diet
por: Olli, Kaisa, et al.
Publicado: (2016)

Alterations of Bacteroides sp., Neisseria sp., Actinomyces sp., and Streptococcus sp. populations in the oropharyngeal microbiome are associated with liver cirrhosis and pneumonia
por: Lu, Haifeng, et al.
Publicado: (2015)

CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients
por: Meng, Dongxiao, et al.
Publicado: (2021)

Non-cirrhotic portal hypertension secondary to cholangiointestinal anastomotic stricture after choledochal cyst excision: a case report
por: Zhang, Xu, et al.
Publicado: (2023)

Venous thromboembolism in in-hospital cirrhotic patients: A systematic review
por: da Cruz Renó, Leonardo, et al.
Publicado: (2022)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

Supplementation of microencapsulated probiotics modulates gut health and intestinal microbiota
por: Gyawali, Ishwari, et al.
Publicado: (2023)

Cirrhotic man with abdominal pain
por: Peng, Carol Chiung‐Hui, et al.
Publicado: (2019)

Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease
por: Hartl, Lukas, et al.
Publicado: (2021)

Prevalence of chronic venous insufficiency and deep vein thrombosis in cirrhotic patients
por: da Cruz Renó, Leonardo, et al.
Publicado: (2023)

Alteration of the serum microbiome composition in cirrhotic patients with ascites
por: Santiago, Alba, et al.
Publicado: (2016)

Mesenchymal stromal cells promote liver regeneration through regulation of immune cells
por: Hu, Chenxia, et al.
Publicado: (2020)

Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Vascular Patterns in the Cirrhotic Liver
por: Wilson, John B.
Publicado: (1951)

De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study
por: Abdel-Razik, Ahmed, et al.
Publicado: (2021)

Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Predictors of Morbidity and Mortality After Colorectal Surgery in Patients With Cirrhotic Liver Disease–A Retrospective Analysis of 54 Cases at a Tertiary Care Center
por: van Beekum, Cornelius J., et al.
Publicado: (2022)

Pediatric Cirrhotic Variceal Bleed Precipitating Diabetic Ketoacidosis
por: Bridwell, Rachel E, et al.
Publicado: (2020)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients
por: Traykova, Daniela, et al.
Publicado: (2017)

Helicobacter pylori Infection in Cirrhotic Patients With Portal Hypertensive Gastropathy: A New Enigma?
por: Alarfaj, Sumaiah J., et al.
Publicado: (2022)

Cirrhotic cardiomyopathy: the liver affects the heart
por: Carvalho, M.V.H., et al.
Publicado: (2019)

Microplastics detected in cirrhotic liver tissue
por: Horvatits, Thomas, et al.
Publicado: (2022)

Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway
por: Zhou, Ziyuan, et al.
Publicado: (2023)

Pasteurella multocida Infection Presented With Frequent Diarrhea in the Cirrhotic Patient
por: Okumura, Hiroki, et al.
Publicado: (2021)

Nutritional Deficiencies and Clinical Practices in Decompensated Cirrhotics With Hepatic Encephalopathy
por: Panchani, Nishah N, et al.
Publicado: (2022)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

A novel therapeutic concern: Antibiotic resistance genes in common chronic diseases
por: Pan, Xiaxia, et al.
Publicado: (2022)

Fecal microbiome in dogs with inflammatory bowel disease and intestinal lymphoma
por: OMORI, Marie, et al.
Publicado: (2017)

The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety Issues
por: Yang, Ya, et al.
Publicado: (2021)

The Relationship Between the Gut Microbiome and Neurodegenerative Diseases
por: Zhu, Xueling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_le0hamlf88thit31vqhbvq9eo0